Clinical trial
Magnevist® Injection-enhanced MRA Compared to Non Contrast MRA for the Detection…
NCT00310557 · Bayer, Industry · Completed
Key facts
| NCT number | NCT00310557 |
|---|---|
| Title | Magnevist® Injection-enhanced MRA Compared to Non Contrast MRA for the Detection of Stenosis of the Renal Arteries |
| Official title | Multicenter, Open-label Study of the Safety (Open-label) and Efficacy (Open-label and Blinded Reader) of a Single Administration of Approximately 0.1 mmol/kg of Magnevist® Injection-enhanced Magnetic Resonance Arteriography (MRA) and 2-dimensional-time-of-flight (2D-TOF) MRA in Patients With Known… |
| Lead sponsor | Bayer, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Renal Artery Stenosis |
| Intervention type | Drug |
| Interventions | Gadopentetate dimeglumine (Magnevist) |
| Enrollment | 116 |
| Start date | Dec 1, 2003 |
| Completion | Dec 1, 2004 |
| First posted | Apr 4, 2006 |
| Last update posted | Dec 30, 2014 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: